Precipio SG&A Expenses 2010-2024 | PRPO
Precipio sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
| Precipio Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $7 |
| 2014 | $7 |
| 2013 | $23 |
| 2012 | $20 |
| 2011 | $19 |
| 2010 | $11 |
| 2009 | $10 |
| Precipio Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | $2 |
| 2015-12-31 | $2 |
| 2015-09-30 | $2 |
| 2015-06-30 | $2 |
| 2015-03-31 | $2 |
| 2014-12-31 | $-9 |
| 2014-09-30 | $5 |
| 2014-06-30 | $6 |
| 2014-03-31 | $5 |
| 2013-12-31 | $5 |
| 2013-09-30 | $7 |
| 2013-06-30 | $5 |
| 2013-03-31 | $6 |
| 2012-12-31 | $4 |
| 2012-09-30 | $6 |
| 2012-06-30 | $5 |
| 2012-03-31 | $5 |
| 2011-12-31 | $5 |
| 2011-09-30 | $4 |
| 2011-06-30 | $6 |
| 2011-03-31 | $4 |
| 2010-12-31 | $3 |
| 2010-09-30 | $2 |
| 2010-06-30 | $3 |
| 2010-03-31 | $2 |
| 2009-12-31 | $2 |
| 2009-09-30 | $2 |
| 2009-06-30 | $3 |
| 2009-03-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.015B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $42.008B | 22.60 |
| Tempus AI (TEM) | United States | $8.309B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.038B | 1124.89 |
| Hims & Hers Health (HIMS) | United States | $3.817B | 222.13 |
| Axonics (AXNX) | United States | $3.550B | 0.00 |
| 10x Genomics (TXG) | United States | $2.732B | 0.00 |
| Enovis (ENOV) | United States | $2.437B | 17.66 |
| Azenta (AZTA) | United States | $2.415B | 137.17 |
| IRhythm Technologies (IRTC) | United States | $2.276B | 0.00 |
| Privia Health (PRVA) | United States | $2.162B | 150.67 |
| Omnicell (OMCL) | United States | $1.979B | 65.18 |
| Clover Health Investments (CLOV) | United States | $1.403B | 0.00 |
| Schrodinger (SDGR) | United States | $1.364B | 0.00 |
| Phreesia (PHR) | United States | $1.313B | 0.00 |
| Standard BioTools (LAB) | United States | $0.713B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.641B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.520B | 441.00 |
| Health Catalyst (HCAT) | United States | $0.503B | 0.00 |
| Talkspace (TALK) | United States | $0.341B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.336B | 0.00 |
| Pulmonx (LUNG) | United States | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
| TruBridge (TBRG) | United States | $0.179B | 13.12 |
| American Well (AMWL) | United States | $0.142B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
| Augmedix (AUGX) | United States | $0.116B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Zepp Health (ZEPP) | China | $0.060B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.037B | 0.00 |
| Outset Medical (OM) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.022B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.022B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |